MED12 and non-small cell lung carcinoma: To investigate the mechanism by which the MED12 mutation induces RTKi resistance, we performed Gene Set Enrichment Analysis (GSEA) based on TCGA data from NSCLC patients with EGFR mutations or ALK rearrangements and compared clinical data according to the presence of MED12 mutations.